Goran Olivecrona, MD, PhD.
Consulting CardiologistUniversity of Lund
Goran Olivecrona, MD, PhD, is a Senior Consultant in the Department of Cardiology at Lund University Hospital, Sweden. He has expertise in interventional cardiology, in particular treatment of acute coronary syndromes and cardiogenic shock with PCI as well as extensive experience in treating CTO's. He also implants percutaneous Aortic valves from both the apical and the femoral approach. Dr. Olivecrona' clinical research interest concerns cardiogenic shock, acute coronary syndromes, and therapeutic hypothermia both following cardiac arrest and in the course of myocardial infarction. He also has experience using novel chest compression devices during Cardiac arrest during PCI. Dr. Olivecrona' basic science research is in the mechanisms governing coronary circulation and reperfusion injury in myocardial infarction. He is the Principal Investigator in Sweden for several multi-center trials in interventional cardiology, including several trials with drug eluting stents. (This is me - Update Profile)
| 1994 - present | Consulting Cardiologist University of Lund |
|---|
GLG Study Groups with Goran Olivecrona, MD, PhD.(?)
| Study Group Name | Members |
|---|---|
| Interventional Cardiologists (EU) | 205 |
| Physicians who Implant Cypher Stents | 91 |
| Physicians who Implant Taxus Stents | 99 |
| Physicians who Implant Both Cypher and Taxus Stents | 88 |
GLG NewsSM Analyses by Goran Olivecrona, MD, PhD.(?)
Retrospective studies should be viewed with caution. Most retrospective studies which may contain a bias in the prescribed treatment should be anlysed with matched propencity score. To confirm the results a randomized trial would essentially be needed.
1. Angioseal is a very user friendly closure device which saves staff time spent with the patient and reduces he number of pseudoaneurysms, but it does not reduce the overall number of bleeding complications. 2. Angioiseal will probably continue to increase its market share in centers not moving...
1. LUCAS can effectively sustain circulation in spite of cardiac arrest through external mechanical chest compressions thus maintaining a sustenance of blood flow to the brain during CPR. 2. Effective external mechanical chest compression devices like LUCAS, offer a new tool to aid in the treatment...
1. ENDEVOR subscribes to cardiologist concerned about the saftey profile of Current DES sold in the US (Cypher and TAXUS). 2. ENDEAVOR seems to carry a higher rate of binary restenosis than Cypher, but may have a lower rate of late stent subacute thrombosis (SAT) than either Taxus or...
GLG InstituteSM Seminars with Goran Olivecrona, MD, PhD.(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Goran Olivecrona, MD, PhD.
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.